uniQure QURE
NASDAQ QURE
$38.32 -4.44 (-10.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

uniQure (QURE) Change in Accured Expenses (2016 - 2026)

uniQure (QURE) posted Change in Accured Expenses of $7.2 million for Q2 2026, up 83.84% on a QoQ basis from $3.9 million in Q1 2026, and up 446.69% year-over-year from $1.3 million in Q2 2025.

Analysis

uniQure (QURE) Change in Accured Expenses (2016 - 2026) Analysis & Trends

uniQure has reported Change in Accured Expenses for 11 years, with the latest figure at $7.2 million in Q2 2026.

  • On a quarterly basis, Change in Accured Expenses rose 446.69% year-over-year to $7.2 million in Q2 2026; TTM through Jun 2026 was $18.8 million, a 610.59% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 179.3% from the prior year.
  • Change in Accured Expenses was $7.2 million for Q2 2026 at uniQure, up from $3.9 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $22.6 million in Q3 2025, with the low at -$14.8 million in Q4 2025.
  • Average Change in Accured Expenses over 5 years is $441833.3, with a median of $215500.0 recorded in 2022.
  • The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses slumped 682.77% in 2024, then soared 537.32% in 2025.
  • Over 5 years, Change in Accured Expenses stood at -$248000.0 in 2022, then surged by 373.79% to $679000.0 in 2023, then plunged by 682.77% to -$4.0 million in 2024, then sank by 275.21% to -$14.8 million in 2025, then soared by 148.27% to $7.2 million in 2026.
  • The last three Change in Accured Expenses figures came in at $7.2 million (Q2 2026), $3.9 million (Q1 2026), and -$14.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 2.32 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 1.20 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 852.00 Mn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 338.00 Mn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 222.50 Mn
10 uniQure 2.96 Bn 2.96 Bn 5.49 Mn 7.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.17 Mn
Mar 31, 2026 3.90 Mn
Dec 31, 2025 -14.85 Mn
Sep 30, 2025 22.59 Mn
Jun 30, 2025 -2.07 Mn
Mar 31, 2025 -1.21 Mn
Dec 31, 2024 -3.96 Mn
Sep 30, 2024 3.55 Mn
Jun 30, 2024 2.88 Mn
Mar 31, 2024 -8.11 Mn
Dec 31, 2023 679,000.00
Sep 30, 2023 5.41 Mn
Jun 30, 2023 -2.41 Mn
Mar 31, 2023 -9.01 Mn
Dec 31, 2022 -248,000.00
Sep 30, 2022 4.93 Mn
Jun 30, 2022 4.78 Mn
Mar 31, 2022 -6.08 Mn
Dec 31, 2021 -2.39 Mn
Sep 30, 2021 6.11 Mn
API Access

uniQure Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=QURE&period=max&api_key=YOUR_API_KEY